carbonyl cyanide m-chlorophenyl hydrazone has been researched along with 1-methyl-4-phenylpyridinium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frei, B; Richter, C | 1 |
| Daniels, AJ; Reinhard, JF | 1 |
| Davis, RE; Miller, SW; Parker, WD; Sheehan, JP; Swerdlow, RH; Tuttle, JB | 1 |
| Cavallaro, S; D'Agata, V; D'Amico, AG; Federico, C; La Cognata, V; Maugeri, G; Saccone, S | 1 |
4 other study(ies) available for carbonyl cyanide m-chlorophenyl hydrazone and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dopamine; Egtazic Acid; Female; Hydroxydopamines; In Vitro Techniques; Mitochondria; NAD; Oxidopamine; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains | 1986 |
Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter.
Topics: 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Ammonium Chloride; Animals; Biological Transport, Active; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carrier Proteins; Catecholamine Plasma Membrane Transport Proteins; Cattle; Chromaffin Granules; Chromaffin System; Dopamine; Hydrogen-Ion Concentration; Kinetics; Membrane Potentials; Membrane Transport Proteins; Neurotoxins; Nigericin; Potassium; Pyridinium Compounds; Serotonin | 1988 |
Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Aged; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Line, Transformed; Cell Membrane; Cytosol; Dopamine Agents; Endoplasmic Reticulum; Energy Metabolism; Female; Homeostasis; Humans; Ionophores; Kinetics; Male; Middle Aged; Mitochondria; Parkinson Disease; Tumor Cells, Cultured | 1997 |
Differential expression of PARK2 splice isoforms in an in vitro model of dopaminergic-like neurons exposed to toxic insults mimicking Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Alternative Splicing; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Differentiation; Cell Line; Cell Survival; Down-Regulation; Humans; In Vitro Techniques; Leupeptins; Models, Biological; Neurotoxins; Oxidopamine; Parkinson Disease; Protein Isoforms; Signal Transduction; Tretinoin; Ubiquitin-Protein Ligases | 2018 |